20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
#3002Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof
#3003Bendamustine pharmaceutical compositions
#3004Pharmaceutical formulation comprising a biopharmaceutical drug
#3005Medicinal composition containing echinocandin antifungal agent micafungin and preparation method and use thereof
#3006Use of oligomers of lactic acid in the treatment of gynaecological disorders
#3007Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
#3008Thermostable Vaccine Compositions and Methods of Preparing Same
#3009Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
#3010Stabilizing composition for biological materials
#3011Antibody formulations and methods
#3012Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase
#3013Collagenase G and Collagenase H compositions for the treatment of diseases involving alterations of collagen
#3014Crystalline form of ertapenem sodium and preparation method therefor
#3015Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#3016Stabilisation of Proteins
#3017VEGF antagonist formulations for intravitreal administration
#3018Methods and compositions for intranasal delivery
#3019Stable liquid VEGF antagonist formulations
#3020Heparain-bulking agent compositions and methods thereof
#3021Modified starch material of biocompatible hemostasis
#3022Formulations and methods for lyophilization and lyophilates provided thereby
#3023Compositions and methods of delivery of pharmacological agents
#3024Silk microspheres for encapsulation and controlled release
#3025Stable formulations for lyophilizing therapeutic particles
#3026Drug loaded polymeric nanoparticles and methods of making and using same
#3027Stable formulations for lyophilizing therapeutic particles
#3028Formulation suitable for stabilizing proteins, which is free of mammalian excipients
#3029Compositions and methods for stabilizing protein-containing formulations
#3030Platelet-rich plasma compositions
#3031COMPOSITIONS OF RECOMBINANT HUMAN ENDOSTATIN ADENOVIRUS INJECTIONS AND METHODS OF PRODUCTION
#3032Thermally stable oil-in-water emulsions containing an oil that contains polyunsaturated fatty acids
#3033Pharmaceutical composition for transcolonic absorption
#3034Cellulose interpolymers and method of oxidation
#3035Polymeric micelles for drug delivery
#3036Lyophilized platelet lysates
#3037Methods of treating, reducing the incidence of, and/or preventing ischemic events
#3038Nanoparticulate composition containing antibiotics for intramammary administration in animals
#3039Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
#3040Protein stabilization formulations
#3041Dihydropyrazoles
#3042Process for preparing curcumin encapsulated chitosan alginate sponge useful for wound healing
#3043Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc
#3044Method for preserving alum adjuvants and alum-adjuvanted vaccines
#3045Protein formulations and methods of making same
#3046Rapamycin composition
#3047Composition comprising tetracyclic compound
#3048Stabilized statin formulations
#3049Formulations for infusion of type B lantibiotics
#3050Cellulose interpolymers and method of oxidation
#3051Bendamustine pharmaceutical compositions
#3052Methods and compositions for intranasal delivery
#3053Stabilisation of viral particles
#3054Fast dissolving pharmaceutical composition
#3055DOSAGE FORM, AND METHODS OF MAKING AND USING THE SAME, TO PRODUCE IMMUNIZATION IN ANIMALS AND HUMANS
#3056Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation
#3057Pharmaceutical formulations
#3058Cellulose interpolymers and method of oxidation
#3059Cellulose interpolymers and method of oxidation
#3060Cellulose interpolymers and method of oxidation
#3061Method of producing lipid nanoparticles for drug delivery
#3062Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseases
#3063Methods for treatment of diseases
#3064Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
#3065Analysis compensation including segmented signals
#3066Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#3067Pharmaceutical formulations
#3068Method and apparatus for preparing novel liposome
#3069HEMOSTATIC COMPOSITIONS
#3070Nucleic acid-lipopolymer compositions
#3071Microtablets for drug delivery
#3072Composition of matter for delivering lipid-soluble materials, and a method for producing it
#3073Oral delivery for hemoglobin based oxygen carriers
#3074INJECTABLE FORMULATIONS FOR PARENTERAL ADMINISTRATION
#3075Levothyroxine formulations
#3076Methods and compositions for tissue regeneration
#3077PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS
#3078Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
#3079Bendamustine pharmaceutical compositions
#3080Lyophilization methods, compositions, and kits
#3081Method for vacuum-assisted preservation of biologics including vaccines
#3082Non-Intravenous Dosage Form Comprising Solid Formulation of Liquid Biologically Active Agent and Uses Thereof
#3083Stabilizing alkylglycoside compositions and methods thereof
#3084Method for Producing a Freeze-Dried Molded Article
#3085Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#3086METHODS FOR REDUCING VEIN IRRITATION
#3087CASPOFUNGIN FORMULATIONS
#3088PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS
#3089Lyophilized anti-fungal compositions
#3090Stabilized antibody-containing liquid formulations
#3091Epoprostenol formulation and method of making thereof
#3092Toll-like receptor agonist formulations and their use
#3093Stabilised solid compositions of factor VII polypeptides
#3094DELIVERY OF IMMUNOGLOBULIN VARIABLE DOMAINS AND CONSTRUCTS THEREOF
#3095POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
#3096Compositions and methods for stabilized polysaccharide formulations
#3097Water Soluble Drug-Solubilizer Powders and Their Uses
#3098Cross-linked compositions
#3099Formulations of recombinant furin
#3100Amniotic membrane preparations and purified compositions and anti-inflammation methods
#3101IN SITU CONSTITUTING A VACCINE FOR ADMINISTRATION TO A PREDETERMINED HERD OF ANIMALS
#3102EPINEPHRINE NANOPARTICLES, METHODS OF FABRICATION THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF CONDITIONS RESPONSIVE TO EPINEPHRINE
#3103Stable bortezomib formulations
#3104Stable bortezomib formulations
#3105Dry growth hormone composition transiently linked to a polymer carrier
#3106Dry glassy composition comprising a bioactive material
#3107FORMULATION COMPRISING AN ANTIBODY AGAINST P-SELECTIN
#3108Antibody formulation
#3109COMPOSITION FOR THE CONTROLLED RELEASE OF BUPRENORPHINE
#3110Compositions and methods for preparation of poorly water soluble drugs with increased stability
#3111Botulinum toxin compositions
#3112Pyrimidinyl pyridazinone derivatives
#3113PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME
#3114COMPOSITION COMPRISING INTERFERON ALPHA
#3115Solid Formulations of Liquid Biologically Active Agents
#3116Process for forming amorphous atorvastatin
#3117Glucagon-like-peptide-2 (GLP-2) analogues
#3118Drug loaded polymeric nanoparticles and methods of making and using same
#3119NIOSOMES, FREEZE-DRIED POWDER THEREOF AND THEIR USE IN TREATMENT
#3120Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
#3121Formulations of Temozolomide for Parenteral Administration
#3122COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS
#3123Glycopeptide phosphonate derivatives
#3124LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF
#3125POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
#3126Formulation of human antibodies for treating TNF-α associated disorders
#3127FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY
#3128Anti-TNF antibodies, compositions, methods and uses
#3129Drug loaded polymeric nanoparticles and methods of making and using same
#3130FLUORINATED 2,6-DIALKYL-3,5-DICYANO-4-(1H-INDAZOL-5-YL)-1,4-DIHYDROPYRIDINES AND METHODS OF USE THEREOF
#3131Method of administering porcine B-domainless fVIII
#3132FORMULATION FOR HGH AND RHIGF-1 COMBINATION
#3133Lipopeptide compositions and related methods
#3134Purified amniotic membrane compositions and methods of use
#3135Multimer of extracellular domain of cell surface functional molecule
#3136Methods for Chronic Pain Management and Treatment using HCG
#3137CHONDROITIN SULFATE-POLYCAPROLACTONE COPOLYMER, METHOD FOR PREPARING THE SAME AND APPLICATION THEREOF
#3138SOLUBILIZED FORMULATION OF DOCETAXEL WITHOUT TWEEN 80
#3139Stable pharmaceutical composition of freeze-dried tetrodotoxin powder
#3140Medical compositions containing ghrelin
#3141EMERGENCY CONTRACEPTIVE
#3142METHODS AND COMPOSITIONS FOR TREATING RHINITIS
#3143Hybrid polypeptides with selectable properties
#3144Medical compositions for intravesical treatment of bladder cancer
#3145ORAL LYSOPHILISATES CONTAINING PVP/VA
#3146Traditional Chinese drug comprising Danshen extracts and Sanqi extracts and use thereof
#3147EMULSION TEMPLATE METHOD TO FORM SMALL PARTICLES OF HYDROPHOBIC AGENTS WITH SURFACE ENRICHED HYDROPHILICITY BY ULTRA RAPID FREEZING
#3148Antibiotic formulations, unit doses, kits, and methods
#3149ORAL LYOPHILIZED COMPOSITIONS
#3150Formulations of diluted amino acid segments and methods for making same
#3151OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS
#3152PHARMACEUTICAL COMPOSITION CONTAINING MEDICAMENT-CONTAINING FINE PARTICLES AND METHOD FOR PRODUCING SAME
#3153HEAT- AND VIBRATION-STABLE INSULIN PREPARATIONS
#3154FORMULATIONS COMPRISING PALONOSETRON
#3155Injectable formulations containing asenapine and method of treatment using same
#3156Pharmaceutical compositions containing botulinum neurotoxin
#3157Pharmaceutical compositions for sustained release delivery of peptides
#3158Compositions containing opioid antagonists
#3159Stable formulations for parenteral injection of peptide drugs
#3160Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes
#3161Formulations of Antibody
#3162PROTEIN NANOPARTICLE DISPERSIONS
#3163Antibiotic formulations, unit doses, kits, and methods
#3164STABLE FORMULATION OF FACTOR VIII
#3165Mixed micelles
#3166DRY POWDER AEROSOLS OF NANOPARTICULATE DRUGS
#3167Organic Compounds
#3168Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
#3169Animal Protein-Free Pharmaceutical Compositions
#3170Stem Cell Conditioned Medium Compositions
#3171PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES ASSOCIATED WITH DECREASE IN BONE MASS COMPRISING EP4 AGONIST AS ACTIVE INGREDIENT
#3172Freeze-dried product for introducing nucleic acid, oligonucleic acid or derivative thereof
#3173Long acting insulin composition
#3174Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
#3175Stable liquid VEGF antagonist formulations
#3176Fas (Apo-1,CD95) targeted platforms for intracellular drug delivery
#3177Stable bortezomib formulations
#3178Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy
#3179METHOD FOR PRODUCING A NUTRACEUTICAL COMPOSITION AND THE NUTRACEUTICAL PRODUCED BY THE METHOD
#3180Alpha-1-antitrypsin compositions and methods of use
#3181Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
#3182Diketopiperazine microparticles with defined specific surface areas
#3183ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF MAMMALIAN DISEASES
#3184Composition for cosmetic, pharmaceutical or dietary applications
#3185Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof
#3186Formulation
#3187Formulations for lysosomal enzymes
#3188Technology for the Preparation of Microparticles
#3189LYOPHILIZING COMPOSITION OF DRUG-ENCAPSULATING POLYMER MICELLE AND METHOD FOR PREPARATION THEREOF
#3190Lyophilized viral formulations
#3191NANODISPERSIONS
#3192STABLE DRY POWDER COMPOSITION COMPRISING BIOLOGICALLY ACTIVE MICROORGANISMS AND/OR BIOACTIVE MATERIALS AND METHODS OF MAKING
#3193Methods and compositions for tissue regeneration
#3194HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONS
#3195NANODISPERSIONS
#3196Compositions and methods for delivery of frozen particle adhesives
#3197Animal protein-free pharmaceutical compositions
#3198Treatment using dantrolene
#3199Treatment using dantrolene
#3200METHODS FOR PRODUCING HIGH CONCENTRATION LYOPHILIZED PHARMACEUTICAL FORMULATIONS
#3201Process for making dry and stable hemostatic compositions
#3202Technology for preparation of macromolecular microspheres
#3203COMPOSITIONS FOR TREATING WOUNDS AND PROCESSES FOR THEIR PREPARATION
#3204PEPTIDE/PARTICLE DELIVERY SYSTEMS
#3205Immunogenic compositions containing phospholipid
#3206LYOPHILIZED FORMULATIONS FOR SMALL MODULAR IMMUNOPHARMACEUTICALS
#3207Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
#3208Compositions and methods for biological remodeling with frozen particle compositions
#3209Pharmaceutical formulation containing gelling agent
#3210Injectable meclizine formulations and methods
#3211Stabilization of interleukin 6 in serum based solutions
#3212Albumin-Free Botulinum Toxin Formulations
#3213Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccines
#3214Compositions and methods for biological remodeling with frozen particle compositions
#3215Dimer VEGF antagonist formulations
#3216Caspofungin Composition
#3217Controlled release sterile injectable aripiprazole formulation and method
#3218Injectable, non-aqueous suspension with high concentration of therapeutic agent
#3219Trans carotenoids, their synthesis, formulation and uses
#3220Denatured lactoglobulin and polyphenol coassemblies
#32213′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
#3222Formulation for stabilizing proteins, which is free of mammalian excipient
#3223VEGF antagonist formulations for intravitreal administration
#3224Factor VII composition
#3225Thermally Stable Oil-in-Water Emulsions Containing an Oil That Contains Polyunsaturated Fatty Acids
#3226Bortezomib formulations
#3227Albumin-free factor VIII formulations
#3228COMPOSITIONS AND METHODS FOR DELIVERY OF SOLUTION TO THE SKIN
#3229Stabilized and lyophilized formulation of anthracycline compounds
#3230Methods for making Apo-2 Ligand using divalent metal ions
#3231Particulate pharmaceutical composition
#3232Cellular compositions for use in therapy
#3233Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
#3234Reduced-viscosity concentrated protein formulations
#3235Solid forms of bendamustine hydrochloride
#3236Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
#3237Polymeric nano-carriers with a linear dual response mechanism and uses thereof
#3238ANTIMICROBIAL COMPOSITIONS
#3239Fine particles of crystalline polyol, and method of preparing same
#3240POLYMERIC PHARMACEUTICAL DOSAGE FORM IN SUSTAINED RELEASE
#3241Dispersions of rasagiline citrate
#3242DRY POWDER COMPOUND FORMULATIONS AND USES THEREOF
#3243SOLID RETIGABINE IN NON-CRYSTALLINE FORM
#3244Processes of making and using pharmaceutical formulations of antineoplastic agents
#3245Compositions and methods for loop diuretics with consistent bioavailability
#3246PHARMACEUTICAL COMPOSITION CONTAINING ARBIDOL IN THE FORM OF PHOSPHOLIPID NANOPARTICLES
#3247Reconstitutable microsphere compositions useful as ultrasonic contrast agents
#3248INTERMEDIATE AND ORAL ADMINISTRATIVE FORMATS CONTAINING LENALIDOMIDE
#3249Methods for reducing vein irritation
#3250STABLE GLUCAGON FORMULATIONS FOR THE TREATMENT OF HYPOGLYCEMIA
#3251Lyophilised dabigatran
#3252Lyophilization cakes of proteasome inhibitors
#3253Burdock fruit extract containing arctigenin at high content and process for producing same
#3254Drug-eluting films
#3255Stable formulations for lyophilizing therapeutic particles
#3256Preservation of bioactive materials by freeze dried foam
#3257AMORPHOUS AMBRISENTAN
#3258METHOD FOR AVOIDING GLASS FOGGING
#3259Solid dispersion of alpha-ketoamide derivatives
#3260Formulations of canfosfamide and their preparation
#3261Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
#3262Diketopiperazine microparticles with defined specific surface areas
#3263Compositions with reduced dimer formation
#3264Methods and compositions for CNS delivery of heparan N-sulfatase
#3265COLLAGEN-BASED HYDROGELS LOADED WITH ZnO QDs/pDNA COMPLEXES AS CORNEAL SUBSTITUES
#3266Methods and compositions for CNS delivery of arylsulfatase A
#3267Compositions and methods of delivery of pharmacological agents
#3268Transmucosal delivery system
#3269Pharmaceutical composition of nanoparticles for protein drug delivery
#3270Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure
#3271Pharmaceutical compositions of dextran polymer derivatives
#3272Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
#3273CNS delivery of therapeutic agents
#3274COMPOSITIONS AND METHODS FOR ENHANCEMENT OF NUCLEIC ACID DELIVERY
#3275TREATMENT OF SANFILIPPO SYNDROME TYPE B
#3276METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASE
#3277Methods and compositions for CNS delivery of iduronate-2-sulfatase
#3278Sustained release of microcrystalline peptide suspensions
#3279PROSAPOSIN AS A NEUROTROPHIC FACTOR
#3280Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
#3281Compositions and methods of delivery of pharmacological agents
#3282DRUG CONJUGATE COMPOSITION
#3283Modified Human Growth Hormone
#3284Polylactide nanoparticles
#3285Methods and compositions for localized agent delivery
#3286HPMA POLYMER PLATINUM CHELATES
#3287Insulin with a stable basal release profile
#3288Disintegrable formulations of lanthanum carbonate
#3289MICROPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS
#3290STABLE INJECTABLE OIL-IN-WATER DOCETAXEL NANOEMULSION
#3291Stable formulations for lyophilizing therapeutic particles
#3292Pharmaceutical composition
#3293Drug loaded polymeric nanoparticles and methods of making and using same
#3294Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
#3295Apo-2 ligand/trail formulations
#3296POLYMERIC MATERIALS LOADED WITH MUTAGENIC AND RECOMBINAGENIC NUCLEIC ACIDS
#3297Partially microcellular, selectively hydrophilic composite construct for ocular drug delivery
#3298POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE
#3299CHLOROTHIAZIDE, CHLOROTHIAZIDE SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#3300Ansamycin hydroquinone compositions